Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kohn

Showing results (491-500 of 516) with videos related to

Pageof 52
Sort By:
Transplantation and Cellular Therapy|October 4, 2025
Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC ReportDanielle E Arnold, Jennifer W Leiding, Brent Logan, et al.
Cell Stem Cell|September 10, 2019
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for CancerYanni Zhu, Drake J Smith, Yang Zhou, et al.
The New England Journal of Medicine|May 11, 2021
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase DeficiencyDonald B Kohn, Claire Booth, Kit L Shaw, et al.
The New England Journal of Medicine|October 9, 2014
A modified γ-retrovirus vector for X-linked severe combined immunodeficiencySalima Hacein-Bey-Abina, Sung-Yun Pai, H Bobby Gaspar, et al.
Nature Communications|April 18, 2024
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessmentMichael D Keller, Patrick J Hanley, Yueh-Yun Chi, et al.
The Journal of Allergy and Clinical Immunology|December 1, 2022
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 DefinitionsChristopher C Dvorak, Elie Haddad, Jennifer Heimall, et al.
The Journal of Allergy and Clinical Immunology|October 22, 2013
Primary Immune Deficiency Treatment Consortium (PIDTC) reportLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
Blood|April 9, 2020
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC reportLauri M Burroughs, Aleksandra Petrovic, Ruta Brazauskas, et al.
Journal of Clinical Immunology|August 4, 2019
Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCTRebecca A Marsh, Jennifer W Leiding, Brent R Logan, et al.
Blood|June 7, 2022
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTCGeoffrey D E Cuvelier, Brent R Logan, Susan E Prockop, et al.
Pageof 52

Showing results (491-500 of 516) with videos related to

Sort By:
Pageof 52
Transplantation and Cellular Therapy|October 4, 2025
Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC ReportDanielle E Arnold, Jennifer W Leiding, Brent Logan, et al.
Cell Stem Cell|September 10, 2019
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for CancerYanni Zhu, Drake J Smith, Yang Zhou, et al.
The New England Journal of Medicine|May 11, 2021
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase DeficiencyDonald B Kohn, Claire Booth, Kit L Shaw, et al.
The New England Journal of Medicine|October 9, 2014
A modified γ-retrovirus vector for X-linked severe combined immunodeficiencySalima Hacein-Bey-Abina, Sung-Yun Pai, H Bobby Gaspar, et al.
Nature Communications|April 18, 2024
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessmentMichael D Keller, Patrick J Hanley, Yueh-Yun Chi, et al.
The Journal of Allergy and Clinical Immunology|December 1, 2022
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 DefinitionsChristopher C Dvorak, Elie Haddad, Jennifer Heimall, et al.
The Journal of Allergy and Clinical Immunology|October 22, 2013
Primary Immune Deficiency Treatment Consortium (PIDTC) reportLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
Blood|April 9, 2020
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC reportLauri M Burroughs, Aleksandra Petrovic, Ruta Brazauskas, et al.
Journal of Clinical Immunology|August 4, 2019
Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCTRebecca A Marsh, Jennifer W Leiding, Brent R Logan, et al.
Blood|June 7, 2022
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTCGeoffrey D E Cuvelier, Brent R Logan, Susan E Prockop, et al.
Pageof 52